Table 4 The histopathological spectrum of patients with nephrotic syndrome at different ages (n = 531)
Pathological diagnosis | 14–24 years n (%) | 25–44 years n (%) | 45–59 years n (%) | >60 years n (%) | Total n (%) | P value |
|---|---|---|---|---|---|---|
MCD | 22 (44.0) | 31 (18.6) | 20 (12.8) | 18 (11.4) | 91 (17.1) | <0.001 |
IgAN | 7 (14.0) | 15 (8.9) | 10 (6.4) | 2 (1.2) | 34 (6.4) | 0.003 |
FSGS | 3 (6.0) | 28 (16.7) | 22 (14.1) | 30 (18.9) | 83 (15.6) | 0.15 |
MGN | 1 (2.0) | 11 (6.6) | 34 (21.8) | 48 (30.4) | 94 (17.7) | <0.001 |
LN | 11 (22.0) | 31 (18.6) | 15 (9.6) | 3 (1.9) | 60 (11.3) | <0.001 |
MPGN | 0 (0.0) | 6 (3.6) | 2 (1.3) | 3 (1.9) | 11 (2.1) | 0.33 |
Renal amyloidosis | 0 (0.0) | 0 (0.0) | 5 (3.2) | 3 (1.9) | 8 (1.5) | 0.08 |
DM | 0 (0.0) | 21 (12.6) | 27 (17.3) | 28 (17.7) | 76 (14.3) | 0.01 |
Others | 6 (12.0) | 24 (14.4) | 21 (13.4) | 23 (14.6) | 74 (13.9) | |
Total | 50 (100.0) | 167 (100.0) | 156 (100.0) | 158 (100.0) | 531 (100.0) |